Literature DB >> 8571826

Regulation of matrix metalloproteinases during extracellular matrix turnover.

M L Corcoran1, D E Kleiner, W G Stetler-Stevenson.   

Abstract

Mesh：

Substances：

Year:  1995        PMID： 8571826     DOI： 10.1007/978-1-4899-1585-6_18

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN： 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  10 in total

1.  Spatiotemporal expression patterns of metalloproteinases and their inhibitors in the postnatal developing rat cerebellum.

Authors:  C Vaillant; M Didier-Bazès; A Hutter; M F Belin; N Thomasset
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

2.  The vimE gene downstream of vimA is independently expressed and is involved in modulating proteolytic activity in Porphyromonas gingivalis W83.

Authors:  Elaine Vanterpool; Francis Roy; Hansel M Fletcher
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

3.  In vivo testing of an injectable matrix gel for the treatment of shoulder cuff muscle fatty degeneration.

Authors:  Tai Huynh; John Taehwan Kim; Grady Dunlap; Shahryar Ahmadi; Jeffrey C Wolchok
Journal:  J Shoulder Elbow Surg       Date:  2020-06-09       Impact factor: 3.019

4.  Inactivation of vimF, a putative glycosyltransferase gene downstream of vimE, alters glycosylation and activation of the gingipains in Porphyromonas gingivalis W83.

Authors:  Elaine Vanterpool; Francis Roy; Hansel M Fletcher
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

5.  A role for trigger factor and an rgg-like regulator in the transcription, secretion and processing of the cysteine proteinase of Streptococcus pyogenes.

Authors:  W R Lyon; C M Gibson; M G Caparon
Journal:  EMBO J       Date:  1998-11-02       Impact factor: 11.598

Review 6.  Matrix metalloproteinases. Novel targets for directed cancer therapy.

Authors:  A E Yu; R E Hewitt; E W Connor; W G Stetler-Stevenson
Journal:  Drugs Aging       Date:  1997-09       Impact factor: 3.923

7.  Anti-metastatic efficacy and safety of MMI-166, a selective matrix metalloproteinase inhibitor.

Authors:  R Maekawa; H Maki; T Wada; H Yoshida; K Nishida-Nishimoto; H Okamoto; Y Matsumoto; H Tsuzuki; T Yoshioka
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

8.  Ovarian expression, localization, and function of tissue inhibitor of metalloproteinase 3 (TIMP3) during the periovulatory period of the human menstrual cycle.

Authors:  Katherine L Rosewell; Feixue Li; Muraly Puttabyatappa; James W Akin; Mats Brännström; Thomas E Curry
Journal:  Biol Reprod       Date:  2013-11-21       Impact factor: 4.285

Review 9.  Gingipain-dependent interactions with the host are important for survival of Porphyromonas gingivalis.

Authors:  Shaun M Sheets; Antonette G Robles-Price; Rachelle M E McKenzie; Carlos A Casiano; Hansel M Fletcher
Journal:  Front Biosci       Date:  2008-05-01

10.  Rodent pharmacokinetic and anti-tumor efficacy studies with a series of synthetic inhibitors of matrix metalloproteinases.

Authors:  O Santos; C D McDermott; R G Daniels; K Appelt
Journal:  Clin Exp Metastasis       Date:  1997-09       Impact factor: 5.150
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.